(NasdaqGM:CURX), Jericho, New York, Oct. 22, 2025 (GLOBE NEWSWIRE) — Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental-stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, has engaged Strategic Investor Relations, LLC, a premier investor relations firm, to enhance Curanex's visibility in the financial community and support its […]

(NASDAQ:VFF), DELTA, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (Nasdaq: VFF) today announced another Canadian first innovation from its Pure Sunfarms brand: the launch of a one-way aroma valve built directly into its dried flower packaging. The one-way aroma valve is pressure-activated and designed to release the flower's scent only

(NASDAQ:MOBX), ~ New contract strengthens Mobix Labs' position as a trusted U.S. defense partner ~ ~ Expanding momentum driven by product sales and strategic acquisitions ~ IRVINE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX), a fabless semiconductor company delivering next-generation connectivity solutions for defense, aerospace, 5G, and high-reliability markets, today

Global Freight and Logistics Expert Brings Over 30 Years of Industry Leadership Experience Freightos Limited (NASDAQ: CRGO), the leading vendor-neutral global freight booking and payment platform, today announced the appointment of Michael Schaecher to its Board of Directors, effective October 19, 2025. This strategic addition further expands the Board's depth of expertise in air and

(NYSE:WGO), — Favorable Product Mix and Targeted Price Increases Drive Solid Top-Line Growth in Q4 — — Efficiency Actions Contributed to Q4 Operating Cash Flow of $181.4 Million — — Balance Sheet Strength Fortified as Leverage Ratio Improves — — Barletta Continues Share Expansion in U.S. Aluminum Pontoon Segment(1) — — Grand Design RV and

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — ATLAS SP Partners (“ATLAS”), the warehouse finance and securitized products business majority owned by Apollo funds, today announced the recapitalization of Atlas Warehouse Lending Company, L.P. (“AWLC”). AWLC is a wholly owned, investment-grade-rated subsidiary of WHCO Intermediate Holdings L.P. (“Atlas Warehouse Company”), which serves as the primary

Pretzl launches with a proprietary AI-driven platform, JourneyLab, to help brands better understand and manage the increasingly complex B2B buyers' journey Today, five longstanding B2B agencies within the Next 15 Group, announce they will combine into one new business: Pretzl. The new B2B marketing business, Pretzl, will fully come to market in February 2026, bringing

ELA026 has demonstrated promising potential as a frontline treatment for patients with sHLH, a hyperinflammatory disease with high mortality and significant unmet medical need Electra has initiated the SURPASS global pivotal trial evaluating ELA026 in patients with sHLH SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Electra Therapeutics, a clinical stage biotechnology company

Proceeds will fund a global pivotal trial of lead product candidate, ELA026, as a frontline treatment for secondary hemophagocytic lymphohistiocytosis (sHLH) Financing will also support indication expansion of ELA026 in hematologic cancers and advance second pipeline program, ELA822, into the clinic for diseases in immunology and inflammation (I&I) Financing co-led by Nextech and EQT Life

The SURPASS study is enrolling patients at research sites across the U.S. and Europe ELA026 targets signal regulatory proteins (SIRP) as a novel approach to treating the life-threatening hyperinflammatory pathology of sHLH SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Electra Therapeutics, a clinical stage biotechnology company pioneering therapies against novel targets for